Adults with inadequately controlled partial-onset seizures while receiving 1 or 2 antiepileptic drugs during an 8-week prospective baseline were randomized to double-blind monotherapy with pregabalin 600 or 150 mg/d ( 4:1 ) for 20 weeks ( 8-week conversion and 12-week monotherapy period ) .